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Abstract The Leishmania granuloma shares some, though
not all, properties with that formed following mycobacterial
infection. As a simplified, noncaseating granuloma composed
of relatively few and largely mononuclear cell populations, it
provides a tractable model system to investigate intra-
granuloma cellular dynamics, immune regulation, and antimi-
crobial resistance. Here, the occurrence of granulomatous pa-
thology across the spectrum of leishmaniasis, in humans and
animal reservoir hosts, is first described. However, this review
focuses on the process of hepatic granuloma formation as
studied in rodent models of visceral leishmaniasis, starting
from the initial infection of Kupffer cells to the involution of
the granuloma after pathogen clearance. It describes how the
application of intravital imaging and the use of computational
modeling have changed some of our thoughts on granuloma
function, and illustrates how host-directed therapies have been
used to manipulate granuloma form and function for therapeu-
tic benefit. Where appropriate, lessons that may be equally
applicable across the spectrum of granulomatous diseases
are highlighted.
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Leishmaniasis: a complex granulomatous disease
The leishmaniases represent some 15 or so human dis-
eases associated with infection by protozoan parasites
of the genus Leishmania. Classification of the leish-
maniases is not straightforward. Often referred to as a
spectrum of diseases, this term implies a continuum in
the clinical spectrum associated with a single etiologi-
cal agent, e.g., as seen for Mycobacterium leprae in-
fection [1]. Most forms of leishmaniasis do show a
spectrum of responses after infection, from the mainte-
nance of an asymptomatic subclinical infection through
to the expression of overt clinical disease with varying
degrees of severity. But for the most part, this spec-
trum exists independently of the well-described clinical
boundaries that distinguish cutaneous, metastatic, and
visceral manifestations of the disease. Hence, it may
be more informative to refer to the leishmaniases as a
Bcollection^ of distinct diseases with different etiologi-
cal agents, each with characteristic and different im-
mune responses and host–pathogen interactions and
each having a spectrum of clinical responses [2, 3].
Different species (and subgenera) of Leishmania char-
acterize disease in the Old World (Europe, Asia,
Africa) and New World (the Americas), reflecting a
combination of evolutionary adaptation and geographic
dispersal of Leishmania parasites and their hosts [4, 5].
Granulomas have been identified following infection with
all species of Leishmania, often associated with the curative
phase of infection.
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Granulomas as hallmarks of protective immunity:
an overview
Some of the most comprehensive studies of the Leishmania
granuloma were conducted by Ridley and Ridley in the early
1980s, who compared different forms and stages of human
cutaneous leishmaniasis using a similar approach to that
adopted in their pioneering histopathological description of
the leprosy spectrum.
They defined many features still relevant today [1]; granu-
lomatous inflammation, mainly showing signs of focal mac-
rophage activation, with or without epitheliod cells, and para-
site destruction, in the absence of neutrophil infiltration; and
granulomas with evidence of macrophage/monocyte lysis and
the presence, albeit transiently, of neutrophils leading to focal
necrosis. However, a more contemporary study of CL cases
found a surprisingly high number of caseating granulomas
(equating to the Ridley group C) [6] It is important to note
that the CL lesion has all the hallmarks of a Bwound^ and as
such, the histopathological features of wound healing, includ-
ing necrotic granulation tissue, fibrinogenesis, and sloughing
off of the lesion, occur in parallel with the antimicrobial func-
tions that are associated with granulomatous inflammation. In
other words, Blesion^ healing may be independent from para-
site killing. This notion is supported by the observation that in
genetic crosses of Leishmania major-susceptible and
Leishmania major-resistant BALB/c and C57BL/6 mice, ge-
netic loci associated with disease severity did not associate
with levels of local immune response, including the extent
of granulomatous inflammation [7, 8].
Granulomas with evident multinucleated and epitheliod
cells are associated with good in vitro recall responses (mea-
sured using the lymphocyte transformation test, LTT) and a
requirement for less drug to achieve healing in Leishmania
braziliensis infection, whereas the presence of necrosis and a
polymorph infiltrate was contraindicated [9]. Lymphocyte,
plasma cells, and occasional eosinophils also predominate in
granulomas in simian models of CL. In L. braziliensis infec-
tions in the Rhesus monkey (Macaca mulatta), chronic gran-
ulomas with all the normal human cellular constituents
(Langhans giant cells, epitheliod cells, plasma cells, parasite-
containing macrophages, lymphocytes) are seen, and at the
final stages of healing there is fibroblast infiltration and fibrot-
ic substitution [10, 11].
In contrast to the skin, the characteristic wound healing
response is rather minimal in systemic sites, providing the
opportunity to examine the antimicrobial functions of granu-
lomas largely independently from this process. However, de-
tailed studies of granulomas in human systemic disease are
few and far between, reflecting the difficulties in sampling
these sites for histopathological investigation. In humans, the
histopathology of active clinical kala-azar most commonly
reflects what might be seen as a failure of granulomatous
inflammation, being associated with extensive lymphoid tis-
sue remodeling, splenomegaly/lymphadenopathy, and elevat-
ed levels of plasma cells [12]. Nevertheless, in some cases,
fibrin-ring granulomas (so named for the donut like appear-
ance due to a ring of fibrinoid material) may be evident in the
liver [13]. A retrospective analysis of liver biopsies in Iran
also suggests that hepatic granulomas may form in some pa-
tients with visceral leishmaniasis [14]. Mirroring the absence
of granulomas in the spleen of active visceral leishmaniasis
(VL) cases, epitheliod granulomas, common in the lymph
nodes of CL patients, are also not usually present in
Sudanese VL patients who present with lymphadenopathy
[15]. Granulomas, usually poorly formed, are also sparse in
the bone marrow [16] [17]. In contrast, asymptomatic patients
have been reported to have epitheliod granulomas in the liver
[18].
In Rhesus monkeys, however, the kinetics of hepatic gran-
uloma formation has been amenable to study. Six weeks post-
experimental infection with 2×107 amastigotes/kg of body
weight of a virulent Leishmania infantum strain, poorly dif-
ferentiated granulomas were observed, largely comprising ag-
gregates of macrophages and lymphocytes. In contrast, by
24 weeks, granuloma organization with the occurrence of
Langhans-type multinucleated cells was observed, with evi-
dent presence of amastigotes. Although this time course of
infection was not extended to determine the rate of involution
of granulomas under these infection conditions, animals re-
ceiving an experimental vaccine for VL (comprising Ad5-
expresing A2 antigen boosted with rA2+IL-12+alum)
showed granuloma resolution at week 24 along with reduced
parasite burden. In the spleens of infected animals, a similar
pattern to human disease was noted, including heavily infect-
ed macrophages in the subcapsular region and red pulp, dis-
organized follicular structures, and sinusoidal congestion.
Again, vaccinated animals had more normal follicular
histology.
In canine VL, both skin [19] and hepatic [20] granuloma
formation has been extensively characterized, demonstrating a
similar trend to that observed in humans and macaques. Thus,
asymptomatic dogs with low parasite burdens had histopath-
ological evidence of robust granuloma formation in the liver,
with evidence of recruitment of effector T cells and local
macrophage/dendritic cell activation. Granulomas were either
not evident or not organized in the liver of symptomatic dogs
with high parasite burdens [20]. Of note, whereas tissue re-
sponse correlated well with parasite load and immune status in
the liver, this appeared less evident in the spleen, mirroring the
organ-specific dichotomy of responses observed in murine
models of VL (see below).
In hamsters, intradermal promastigote inoculation lead to
neutrophil influx over the first 48 h followed by a mononu-
clear cell-rich granuloma that was coincident with clearance of
parasites from the skin [21, 22]. Nevertheless, this local
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response did not stop dissemination and the ultimate develop-
ment of VL in this model. It was also suggested from these
studies that visceral dissemination might need to occur before
granuloma formation [21].
Mice infected intravenously with amastigotes of
Leishmania donovani or L. infantum have provided multiple
insights into the fine detail of granuloma formation [23], as
described in the following sections. Nevertheless, it is worth
noting here that mice represent something of a hybrid when it
comes to modeling the response observed in humans.
Whereas the granulomatous response in the hepatic microen-
vironment appears to follow many of the characteristics ob-
served in subclinical human and canine infection and in the
ultimately self-resolving infection in primates, the spleen fails
to make a robust granulomatous response and shows hall-
marks of progressive human, primate, and canine disease.
This expression of organ-specific immunity, within the same
genetically and microbiota-defined host, provides a clear ex-
ample of the compartmentalization of immune responses
based on tissue-specific environmental factors [12, 24].
Post kala-azar dermal leishmaniasis is an important but
relatively understudied sequelae of visceral leishmaniasis
[25–28]. In Sudan, where post-kala-azar dermal leishmaniasis
(PKDL) is commonly self-limiting, granulomas were reported
in ∼20 % of patients, though other signs of chronic inflamma-
tion, e.g., the presence of giant cells, were more frequently
observed [29, 30]. In India, where PKDL is less frequent but
more chronic in nature, granuloma formation was notably
absent, suggestive of a causative relationship between granu-
loma formation and host protection [31].
Initiation of the hepatic granulomatous response
in mice
Experimental murine models of VL have played an important
role in understanding the development of granulomatous
inflammation in the hepatic microenvironment. It should
be emphasized at the outset, however, that this represents
very much a model system and that many aspects of the biol-
ogy of natural infection are omitted from the model. Natural
sandfly-mediated transmission of small numbers of
Leishmania metacyclic promastigotes into the dermis is re-
placed by the intravenous administration of large (often very
large!) numbers of culture-derived promastigotes (most com-
mon when using Leishmania chagasi/infantum) or
amastigotes (commonly used for L. donovani). Although
new imaging approaches have highlighted the novel route of
Plasmodium transmission to the lymphatics during mosquito
blood feeding [32], our current knowledge of sandfly trans-
mission of Leishmania suggests that parasites are deposited in
the dermis, where they may be engulfed by neutrophils, der-
mal macrophages, or dermal DCs [3]. Sandfly salivary
components also have a direct capacity to modulate local
and perhaps systemic immune responses, and this may alter
the hepatic microenvironment. Whether visceralisation of
Leishmania to the liver and elsewhere is accomplished by free
parasites (unlikely) or by migratory infected myeloid cells
(more likely) has yet to be determined experimentally. In part,
this technical challenge is one of numbers—tracing a few
initiating foci of infected Kupffer cells within the myriad si-
nusoidal network of the liver is a major challenge.
Hence, what we know about the initiation of granuloma-
tous inflammation in the liver begins from the somewhat arti-
ficial starting point of an interaction between free amastigotes
and liver resident cells lining the sinusoidal spaces of the
healthy non-inflamed liver. Under these infection conditions,
the Kupffer cell is the primary target of L. donovani
amastigotes. Early immunohistochemical analysis identified
Kupffer cells on the basis of their characteristic morphology
and anatomical position within the sinusoids [33]. Later, using
real-time intravital 2-photon imaging, the uptake of
amastigotes in situ was visualized for the first time. Kupffer
cells are the resident tissue macrophages of the liver, originat-
ing from a wave of primitive yolk sac hematopoiesis that starts
around embryonic day E7.5 and involves a myb-independent
precursor [34, 35]. Using a LysMcre reporter mouse crossed
to the dual-color reporter mouse line mT/mG, Beattie et al.
demonstrated that Kupffer cells are stationary within the sinu-
soids and display elegant membrane activity, with continuous-
ly extending and retracting lamellipodia activity [36, 37].
Following contact with injected amastigotes, uptake is rapid
and completed within minutes, with no obvious change in
lamellipodia activity either at the contact site or distal to it
(Fig. 1a; Supplementary Movie 1 and [36]. Phagocytosed
amastigotes were observed to reside within intracellular vac-
uoles from the earliest timepoint that can be studied (Fig. 1b
and Supplementary Movie 2; Beattie, unpublished).
Uptake of Leishmania by macrophages has been shown to
be dependent on both host cell type and parasite species and
involve distinct mechanisms in vitro [38, 39]. The intravital
imaging data described above demonstrate that within the liv-
er microenvironment, phagocytosis of amastigotes by Kupffer
cells is a relatively passive process, displaying none of the
indicators of induced phagocytosis or macropinocytosis. A
currently unanswered, yet tractable question that follows from
these imaging studies is the nature of the ligand responsible
for amastigotes recognition and uptake. In vitro studies have
identified a range of potential receptor ligand pairs involved in
Leishmania–macrophage interactions and their relevance
in vivo deserves to be exploredmore fully [38]. A recent study
identified divergent roles for the C-type lectins SIGNR3,
dectin1, and mannose receptor in determining the fate of
L. infantum. Whereas SIGNR3 favored parasite survival
through selective modulation of LTB4-IL-1β, both dectin1
and MR were coupled to signaling pathways associated with
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ROS production [40]. Although neutrophils were also observ-
able patrolling the sinusoidal spaces in these imaging studies,
they appeared to make little contact with L. donovani
amastigotes and only rarely was phagocytosis directly ob-
served. This is in contrast to the rapid engulfment of intrave-
nously inoculated promastigotes of L. donovani by neutro-
phils (Fig. 1c and Supplementary Movie 3). The lack of im-
mediate neutrophil swarming into the liver postinfection
(a characteristic of promastigote inoculation; Beattie, unpub-
lished) also confirmed the relative lack of inflammatory stim-
uli triggered by amastigotes under these conditions.
Neutrophil indifference to amastigotes compared to
promastigotes has also been reported for other Leishmania
spp. in vitro [41].
Intravital imaging studies of BCG-infected mice showed a
remarkably similar picture for the uptake of this mycobacteri-
um; BCG was internalized by KCs within a minute or so of
intravenous injection and became associated with intracellular
compartments within 5 min of contact. Neutrophils, when
observed patrolling the sinusoidal space, did not appear to
engulf or contact BCG organisms in any appreciable manner,
and this apparent indifference was also apparent even after the
neutrophil influx characteristic of the early stages of BCG-
induced inflammation [42].
Chemokines and cytokines regulating early
mononuclear cell recruitment
Mononuclear cell recruitment into the nascent granuloma can
occur by local repositioning of resident Kupffer cells or
through the initiation of inflammation. Early during the pro-
cess of granuloma formation, Kupffer cells may fuse, resulting
in multinucleation [23] (Fig. 1d and SupplementaryMovie 4).
This process involves both infected and uninfected Kupffer
cells, implying cues for local detachment and migration along
the sinusoidal endothelium. Such Kupffer cell motility was
also observed using BCG infection, and in both model sys-
tems, areas of Kupffer cell-rich granulomatous inflammation
become interspersed with areas of the sinusoidal network de-
void in their resident macrophages [37, 42]. Notably, the fate
of Kupffer cells and their propensity to either form multinu-
cleate cells or aggregates appears independent of parasite load,
with some heavily infected Kupffer cells remaining as single-
tons in the highly inflamed liver environment for protracted
periods of time (Fig. 1e and f and Supplementary Movies 5
and 6). This evident heterogeneity underlying granuloma for-
mation provides a context for the development of computa-
tional simulations that aim to provide a mechanistic under-
standing of this observation (see below). Comparison with
the behavior of Kupffer cells in BCG and L. donovani granu-
lomas also serves to emphasize the relatively static nature of
these cells/aggregates once within the core of the granuloma
Fig. 1 Intravital imaging of granuloma formation in experimental
L. donovani infection. a–g Intravital analysis of KC (green) in liver
sinusoids (red) in (mT/mG×LysMcre)F1 mice; a immediately following
intravenous injection of tdTomato L. donovani amastigotes, b 2 h post-
injection of tdTomato L. donovani amastigotes, c immediately following
intravenous injection of tdTomato L. donovanimetacyclic promastigotes,
d–f 6 days post-injection of tdTomato L. donovani amastigotes. g CFSE-
labeled memory-like OT-I T cells (green) 5–14 h post-transfer into d14-
21-infected hCD2.RFP mice (red T cells) infected with OVA-transgenic
L. donovani. All images represent snapshots of the extended focus view
of time-lapse imaging sequences. Associated videos are provided as
Supplementary Movies 1–7. For further experimental details, see refer-
ences [36, 37].
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[37, 42], and although it is not possible to formally rule out,
under the imaging conditions used, that some singleton-
infected Kupffer cells arise from migration of Kupffer cells
out of the granuloma environment, as noted in the granulomas
formed in zebrafish infected withMycobacterium marinarum
[43], there is no current evidence to support this from studies
in the immunologically intact mouse.
As infection proceeds past the first few hours, inflammato-
ry cells begin to be recruited to the infected liver, and more
specifically to infected Kupffer cells. Conventional ap-
proaches to examining the factors responsible for regulating
tissue recruitment of inflammatory cells involves measure-
ment of total tissue-derived chemokines/cytokines. We and
others have used this approach to show early chemokine pro-
duction, notably CCL2, CCL3, and CXCL10 [44–48]. In
some instances, the functional importance of these factors
has been validated by the use of gene-targeted mice in which
there has been global loss of production of the factor under
study. In common with similar studies using BCG and MTB,
these experimental approaches provide valuable information
about the cellular environment underlying the inflammatory
event but fail to provide information regarding the cell-
specific nature of these responses. Chemokines in particular
are difficult to study by conventional immunohistochemical
techniques, limiting the spatial information available. In some
cases, ex vivo analysis of chemokine production has been
performed following flow cytometry, but this has been on a
rather piece-meal gene by gene basis. The importance of spa-
tial information is exemplified by our analysis of CXCL10
regulation. Messenger RNA (mRNA) accumulation for
Ccl2, Ccl3, and Cxcl10 was coordinately increased at 2 h
postinfection in both wild-type mice and immunodeficient
SCID or Rag1 −/− mice [44, 48], and Ccl2 and Ccl3 mRNA
returned to baseline levels by 24 h in both strains of mice [44].
In contrast, wild-type but not immunodeficient mice exhibited
sustained accumulation of Cxcl10 mRNA, indicative of the
IFNγ-regulated nature of this chemokine. Surprisingly, how-
ever, given that IFNγ-producing NK cells, non-invariant
NKT, and invariant NKTcells could all be detected in the liver
at this time, studies in Jα281−/− mice indicated that only in-
variant NKT cells produced IFNγ that was functionally rele-
vant in this context [48].
In order to determine the global Kupffer cell response to
infection, we developed an ex vivo transcriptomic profiling
approach, wherein infection with TdTomato-expressing trans-
genic parasites allowed us to rapidly sort both infected and
uninfected Kupffer cells from the liver of the same infected
mouse. By comparison to Kupffer cells isolated from infected
mice, this provided a unique opportunity to not only identify
transcripts associated with the presence of intracellular
amastigotes, but also to reveal how Kupffer cell activation
proceeds in trans in response to inflammation [36]. This tech-
nique identified transcriptional signatures common to infected
and Binflamed^ Kupffer cells (largely mapping to GO terms
associated with host defense and inflammatory response and
validating many of the chemokine pathways identified earlier)
and also signatures unique for infected cells (often associated
with the regulation of macrophage gene expression and pro-
tein production). Surprisingly, we identified 241 transcripts
uniquely regulated in the Binflamed^ but not infected popula-
tion of Kupffer cells. One explanation for this finding was that
parasitism was favored by maintaining these genes at homeo-
static levels even in the face of inflammation; hence, these
genes might regulate a presumptive host defense pathway
the parasite is avoiding. To test this hypothesis, we used phar-
macologic intervention to perturb one of these regulatory gene
networks, involved in lipidmetabolism, and demonstrated that
indeed this led to more effective Kupffer cell control of
amastigote replication [36].
Other studies have examined the impact of gene KOon early
myeloid cell recruitment. Ccr5, Ccl3, and Ccr2 KO mice all
haveKC aggregates of reduced size at 4 days p.i., with impaired
granuloma organization measurable at 4 weeks [49]; similar
defects were noted in a model of PPD-coated latex bead-
induced lung granulomas in Ccr2 KO mice [50] and also in
Ccr1 KO mice in the Schistosoma egg granuloma model [51].
IL-33 is a Th2-associated cytokine that belongs to the
alarmin family and that signals via the ST2 (Il1rl1)/IL-1 re-
ceptor accessory protein complex. IL-33 is produced by innate
lymphoid cells and also by many non-hematopoietic cells.
CCL2 and CXCL2 and their receptors (CCR2 and CXCR2)
are increased in expression in hepatic tissues in infected Il1rl1
KO BALB/c mice coincident with enhanced Th1 responses
and granuloma development and monocyte and neutrophil
recruitment. These data suggest that signaling through ST2/
Il1rl1 is a negative regulator of granuloma formation [52].
Cxcr3 KOmice, defective in responsiveness to CXCL9 and
CXCL10, have delayed granulomatous responses but show
otherwise effective antimicrobial function [53]; A similarly de-
layed response to aerosolized MTB infection was noted in
Cxcr3 KO mice, suggesting that neutrophils were important
for regulating early inflammation, though ultimately clearance
of infection was obtained in these mice [54]; hence, Cxcr3 was
not essential for immunity to L. donovani but allowed optimal
recruitment of leucocytes to the granuloma [53].
Jα281 KO mice defective in invariant NKT cells have de-
layed granuloma formation, and 90 % of all chemokine, cyto-
kine, and associated receptor genes upregulated in the livers of
wild-type (WT) L. donovani-infected mice were found to be
underexpressed in similarly infected Jα18 KO mice,
underscoring the global deficiency in early stages of granulo-
ma formation in these mice [55].
The precise upstream signaling that drives these inflamma-
tory chemokine responses in infected and inflamed Kupffer
cells is poorly characterized. Tlr2 KO mice infected with
Leishmania amazonensis have eosinophilic granulomas in
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the early stages of infection compared to the mononuclear-rich
responses ofWTmice, suggesting that this TLR can modulate
the balance of myeloid cell recruitment [56]. In L. donovani
infection, TLR2 appears to negatively regulate granuloma for-
mation, with more rapid granuloma maturation occurring in
Tlr2KOmice; in contrast, TLR4 signaling appears to dampen
the development of this response, and heavily parasitized
granulomas persist. Importantly, the mechanisms of granulo-
ma involution/resolution were not dysregulated in the absence
of Tlr2, and such mice did not develop fulminating granulo-
matous pathology [57].
TLR9 is a PRR involved in the early recognition of
Leishmania under some circumstances [58]. TLR9 expression
has been demonstrated in granulomas from L. braziliensis pa-
tients but the evolution of this response was not studied and
may relate to TLR9 regulation on macrophages after granulo-
ma formation [59]. TLR9 has also been implicated in the
initial response to L. infantum promastigotes in mice, acting
as part of a regulatory network that controls NK cell IFNγ
production. The impact of Tlr9 deficiency on granuloma for-
mation was not, however, reported [58].
IRF5 can be activated downstream of TLR9/Myd88 and
TLR7/Myd88 signaling. Irf5 KO mice infected with
L. donovani have delayed Th1 responses, higher liver parasite
burdens, and smaller Th2-biased granulomas with greater ev-
idence of neutrophil involvement and concomitant accumula-
tion of Cxcl1 mRNA in the granuloma [60]. A similar pheno-
type was also noted in Tlr7 KO mice. Although TLR7
operates via IRF7 as well as IRF5, no effect on splenic or
Th1 responses (measured as CD4+ T cell-derived IFNγ in
the liver or spleen) was noted as a consequence of Irf7 defi-
ciency in this study. In contrast, another study using Irf7 KO
mice demonstrated a reduction in granuloma formation, Th1
response, and local NO response, along with an increase in the
frequency of CD4+ Tcells committed to producing IL-10 [61].
Exemplifying the divergent mechanisms of tissue and cellular
control of Leishmania, Irf7-deficient Kupffer cells were
shown to have an intact innate response to amastigotes of
L. donovani, compared to the defective response seen in
splenic marginal zone macrophages [61].
Given its role in regulating the Th1 response, the finding
that Tbet-deficient mice are highly susceptible to L. donovani
infection was not unexpected. Although granuloma formation
proceeds in these mice, albeit in a restricted manner, most
measures of Th1 immunity are significantly compromised.
In contrast, and unexpectedly, Stat1-deficient mice are highly
resistant to L. donovani infection, with minimal or absent
granuloma formation in these mice [62]. Of note, granuloma
formation was equivalent in Rag2KOmice that received wild
type or Stat1-deficient T cells by adoptive transfer, demon-
strating that induction of granulomatous pathology was regu-
lated through STAT1-dependent pathway(s) operating in non-
lymphoid cells [62].
Although limited in the granulomas of wild type
L. donovani-infected mice, there is increasing evidence that
neutrophils regulate granuloma formation in experimental
VL. Delayed granuloma formation was observed in mice de-
pleted of neutrophils using mAb NIMP-R14, but this was far
less of an effect than that observed on parasite load in the
spleen and BM [63]. In B cell-deficient μMT mice, neutro-
philic infiltration was exaggerated, leading to widespread he-
patic necrosis, rarely seen in wild-type mice infected with
L. donovani. In the context of B cell deficiency, neutrophil-
mediated pathology could be ameliorated by passive transfer
of Ig [64].
The maturing granuloma: a focus for cell-mediated
immunity
Analysis of the cytokine response in the maturing hepatic
granuloma has been the focus of intense study for over three
decades [65], and extensively reviewed onmultiple occasions,
often contrasting the host protective granulomatous response
with the non-protective and non-granulomatous response seen
in the spleen [12, 23, 24, 66, 67]. The reader is referred to
these articles for a current overview. In summary, granuloma-
tous inflammation appears the preferred route for focusing
cytokine secretion onto infected macrophages, with the aim
of stimulating the production of toxic anti-leishmanial species
including nitric oxide and superoxide. Although Th1-like re-
sponses dominate (with IFNγ being produced bymultiple cell
types) and alternatively activated macrophages are sparse in
the L. donovani granuloma, the Th2-associated cytokines IL-4
and IL-13 are nevertheless required for optimal granuloma
formation [68, 69]. As Kupffer cells contain the vast bulk of
amastigotes in the murine hepatic granuloma [37], it is likely
that this macrophage population is responsible for parasite
elimination. However, it remains possible that Kupffer cell
lysis occurs and that leishmanicidal activity is delivered by
granuloma-infiltrating monocytes or neutrophils that rapidly
phagocytose the released amastigotes.
It is worth bearing in mind, however, some of the experi-
mental limitations of many of these studies, when it comes to
precisely assigning the role of cytokines and/or cells within
the microenvironment of the granuloma per se. For example,
technical challenges associated with the small size and limited
structural integrity of the L. donovani granuloma makes iso-
lation difficult and often whole liver cell populations are used
for analysis as a surrogate. Alternatively, the experimental
intervention may affect immune regulation within the granu-
loma, but it also likely has more global effects (e.g. consider
the mouse treated with mAb to neutralize a given cytokine),
that indirectly affect granuloma form or function. Finally,
while granuloma heterogeneity (cellularity, location, or appar-
ent microbicidal activity) is clearly evident even by simple
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histological analysis, aggregation of data from this heteroge-
neous population is the current norm. Unlike studies on TB,
where ex vivo access to and/or imaging of individual granu-
lomas in situ is possible [70–72], our ability to interrogate the
individual granuloma in leishmaniasis patients and animal
models remains limited at present.
Attempts to isolate the hepatic environment from other
systemic sites responding to their own Blocal^ Leishmania
infection have provided some insights into the independence
of hepatic immunity, but largely not addressed the challenge
of defining responses within the granuloma microenviron-
ment per se. For example, in aly/aly mice that lack LN,
Peyer’s patches, and have disrupted splenic architecture, gran-
ulomas are generated in the liver [73]. This is in keeping with
recent data showing that splenectomized LT-deficient mice
(also lacking LNs, hence devoid of conventional secondary
lymphoid tissue) have the capacity to mount immune re-
sponses against this infection including normal granuloma
formation [74]. In the case of aly/aly mice, parasites persist
within granulomas accompanied by an influx of Foxp3+ Tregs
that is not seen in granulomas of WT mice [73].
Intravital microscopy provides the opportunity to study in-
dividual granulomas in situ in live animals, but imposes its
own constraints. Imaging windows are short, usually a few
hours at most, and the procedures used are terminal, limiting
the observation of granulomas over realistic time periods to
observe their maturation. Observation is generally limited to
one or a small number of cell populations, and the functional
consequences of those interactions, be that intracellular sig-
naling events or cytokine production, are only recently be-
coming amenable to imaging [75]. Nevertheless, the study
of CD4+ T cell [42, 76, 77] and CD8+ T cell behavior within
the BCG and L. donovani [37, 78] granuloma has provided
valuable novel insights into local effector T cell activity
(Fig. 1g and SupplementaryMovie 7). In spite of these studies
focusing on different Tcell subsets, commonalities emerge: (i)
both antigen-specific and non-specific T cells are recruited
into the granuloma—a not unsurprising finding given the in-
flammatory nature of this environment, but one that serves as
a reminder that enumeration of all T cells in the granuloma is
not a likely measure of effector function; (ii) T cells move
freely into and out of granulomas, with no evident walling-
off of the granuloma from its external environment; (iii) with-
in granulomas T cell velocity was similar to that seen in orga-
nized lymphoid tissues, but other measures of T cell migration
indicated some local constraints on free migration within the
confines of a granuloma; (iv) long-term contacts between T
cells and APC, indicative of cognate interactions and measur-
able by a dwell time for granuloma exit, was observed for a
minority of antigen-specific T cells, suggesting local presenta-
tion of cognate antigen was limiting. This conclusion is support-
ed in the case of CD4+ Tcells by demonstrating arrest of a much
greater frequency of intra-granuloma T cells after exogenous
administration of peptide [76]. Within the L. donovani granulo-
ma, expression of MHCI-peptide complexes was an almost ex-
clusive property of infected Kupffer cells and such cells formed
the focus of attention for CD8+ Tcells [37]; and (v) constraints on
APC efficiency within the granuloma may reflect limited MHC-
peptide complex expression coupled to local pathogen load [76,
77] or altered expression of checkpoint inhibitors [79].
These studies provide a basis for future examination of
other aspects of granuloma biology that may be pertinent to
understanding disease chronicity and or targeted therapeutic
intervention. For example, whether T cell behavior remains
similar across the spectrum of granuloma heterogeneity is un-
known, and how changing features of the non-lymphoid com-
partment of the granuloma including progressive fibrosis, may
affect T cell–APC interactions would appear to be an essential
route of future investigation. Likewise, the role of checkpoint
inhibitors as host-directed therapy has a proven experimental
base (see below) but whether this occurs through direct ma-
nipulation of T cell biology in the granuloma remains to be
established. As pointed out by Germain and colleagues [76],
manipulation of local APC function may prove more profit-
able than or be an effective adjunct to enhancing effector Tcell
frequency, and in situ analysis of the type described above
may provide the most useful means to monitor the success
of such interventions.
Computational simulation of granuloma
development and function
To overcome some of these experimental limitations and
to gain further insight into granuloma heterogeneity, dy-
namics, and function, we and others have also adopted
computational approaches. In TB, these models have
focused largely on understanding macrophage polarization
and the role of TNF [80–82].
Our approach in modeling the L. donovani granuloma has
been twofold—first, the generation of agent-based models of
early granuloma formation and, second, the use of Petri net
modeling of granuloma heterogeneity and within granuloma
immune interactions. The former have been discussed else-
where [83] and will not be considered further here. The Petri
net model that we have used to evaluate the development of
granulomas and the emergent immune regulation that influ-
ences parasite load is not spatially explicit and assumes no
structural organization within the granuloma per se. It has,
however, provided invaluable insights into potential sources
of granuloma heterogeneity and allowed us to postulate the
presence of a small subset of granulomas that have altered
immune regulatory function that leads to parasite persistence
[84]. Such granulomas may well be a source of recrudescence
upon immune suppression, a common feature of experimental
models of VL and also seen in human disease, and the
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generation of new hypotheses amenable to experimental val-
idation is arguably one of the central roles that modeling can
play in understanding complex, dynamic, and long-lived dis-
ease processes.
The granuloma as a tertiary lymphoid organ
Tertiary lymphoid organs are commonplace in conditions
of chronic inflammation, representing accumulations of
lymphoid cells and stromal cells that recapitulate aspects
of lymphoid tissue architecture [85]. In autoimmune dis-
eases, the production of tertiary lymphoid organs (TLOs)
is increasingly recognized as a poor prognostic indicator,
serving to perpetuate the immune response. Lung TLO’s
have also been reported in mice infected via aerosol with
Mycobacterium tuberculosis H37RV and in human tuber-
culosis, associated with granulomas [86–88]. Central to
the formation of TLOs is the lymphotoxin-dependent ap-
pearance of stromal cells producing constitutive
chemokines associated with lymphocyte aggregation.
Notably, most TLOs express CXCL13, the chemokine
produced by follicular dendritic cells and responsible for
B cell aggregation in germinal centers [89]. Hence, cur-
tailment of the production and maintenance of TLOs is
viewed as a potential target for stromal cell-targeted
host-directed therapy. Although B cells are found within
the granulomas of L. donovani-infected mice, and these
make sustained interactions with granuloma T cells that
are suggestive of cognate interactions [90], we have not
found evidence for TLO-like organization either within
the granuloma itself or within the hepatic microenviron-
ment during L. donovani infection. CXCL13 expression
was not detectable nor were cells expressing the FDC
marker FDCM1. The reasons for the lack of TLO forma-
tion during L. donovani infection are currently unknown.
One possibility is that the relative paucity of strong
PAMPs in Leishmania compared to MTB limits the extent
of underlying innate immune responses that drive TLO
formation. On the other hand, the relative ease with which
Leishmania succumb to macrophage leishmanicidal activ-
ity may allow premature truncation of the infection before
TLOs can fully develop. Alternatively, Leishmania infec-
tions may not provide appropriate signals for the recruit-
ment and activation of lymphoid tissue inducer (LTi)
cells. LTi cells are a necessary precursor to TLO forma-
tion. In support of this latter possibility, whereas restora-
tion of lymphoid tissue architecture following MCMV
infection is dependent upon LTi function [91], such cells
do not appear to play a role in restoration of lymphoid
tissue architecture in L. donovani-infected mice treated
with sunitinib maleate, a receptor tyrosine kinase inhibitor
that restores stromal cell structure and function [92].
Host-directed therapies targeting granulomatous
inflammation
The therapeutic benefit of modulating key pathways in im-
mune regulation on the outcome of L. donovani infection pro-
vided some of the earliest examples of the use of checkpoint
inhibitors, now an increasingly popular clinical intervention
strategy for cancer and autoimmunity [93, 94], as tools to
manipulate immunity to pathogen infection. Following obser-
vations that the expression of costimulatory molecules of the
B7 family were reduced in expression on infected Kupffer
cells at the core of the granuloma [79] and on L. donovani-
infected macrophages in vitro [95], mAb targeting
costimulatory pathways were examined for their ability to
affect granuloma formation and host protective immunity.
Administration of a blocking antibody to B7-2 (CD86) had
no impact on early immune or inflammatory responses,
whereas later administration led to enhanced Th1 responses
and granuloma formation. These data suggested that late
CD86-CTLA4 interactions might limit the expression of max-
imum immunity to L. donovani [96]. Confirming this predic-
tion, administration of a mAb (4F10) targeting CTLA-4 was
shown to significantly accelerate granuloma formation and
lead to significant reductions in tissue parasite burden.
Notably, anti-CTLA4 could be used therapeutically in mice
with established infection, either alone [97] or in a synergistic
fashion with conventional chemotherapy [98, 99]. Other
checkpoint regulators including OX40L-Fc [98], anti-CD40
[99], and PDL-1 [100] have proven equally effective at en-
hancing granuloma formation and protective immunity in
chronically infected mice, in the absence of any overtly
tissue-damaging pathology. To date, no clinical trials of such
checkpoint inhibitors have been performed in the context of
leishmaniasis, although evidence for defects associated with
dysregulated checkpoint control, e.g., CD8+ Tcell exhaustion,
have been obtained in the clinic [101]. Attempts to validate the
use of checkpoint-regulating antibodies with in vitro cultures
of infected macrophages and T cells have had mixed results,
with the PD-1 pathway blockade inducing heightened macro-
phage activation and parasite killing in cells obtained from
active cases of canine VL [102] but not human VL [101].
The success of checkpoint blockade in models of
L. donovani infection is not mirrored in models of mycobac-
terial infection. For example, whereas CTLA4 blockade sig-
nificantly increased multiple correlates of immunity in mice
infected with BCG, there was no impact on mycobacterial
load in the spleen, liver, or lung and no changes to lung his-
topathology and granuloma formation [103]. Importantly, re-
moval of regulatory control over T cell activation during my-
cobacterial infection may lead to the development of overt
pathology, as in the case of manipulation of the PD-1 pathway
[104]. It is likely that differences in outcome of checkpoint
regulation related to pathology vs. protection reflect the
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relative ease with which Leishmania succumbs to the antimi-
crobial defenses compared to mycobacteria and to differences
in the inherent immunogenicity of these organisms, with
Leishmania being a renowned Bsilent invader^ [3]. These
characteristics may suggest a brighter future for checkpoint
inhibitors as therapeutic agents in human leishmaniasis com-
pared to mycobacterial disease.
Acknowledgments Research in the authors’ laboratories is funded by
the UK Medical Research Council (to PMK) and The Australian
Infectious Diseases research network and QIMRB (to LB). The authors
thank all those in the Kaye laboratory, past and present, that have con-
tributed to the understanding of granulomatous pathology in experimental
leishmaniasis. The authors also apologize to those whose work was not
cited due to constraints on space.
Compliance with ethical standards
Conflict of interest The authors declare that they have no competing
interests.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
1. Ridley MJ, Ridley DS (1986) Monocyte recruitment, antigen deg-
radation and localization in cutaneous leishmaniasis. Br J Exp
Pathol 67:209–218
2. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P et al (2012)
Leishmaniasis worldwide and global estimates of its incidence.
PLoS One 7, e35671
3. Kaye P, Scott P (2011) Leishmaniasis: complexity at the host-
pathogen interface. Nat Rev Microbiol 9:604–615
4. Lukes J,Mauricio IL, SchonianG, Dujardin JC, Soteriadou K et al
(2007) Evolutionary and geographical history of the Leishmania
donovani complex with a revision of current taxonomy. Proc Natl
Acad Sci U S A 104:9375–9380
5. Tuon FF, Neto VA, Amato VS (2008) Leishmania: origin, evolu-
tion and future since the Precambrian. FEMS Immunol Med
Microbiol 54:158–166
6. Aoun J, Habib R, Charaffeddine K, Taraif S, Loya A et al (2014)
Caseating granulomas in cutaneous leishmaniasis. PLoS Negl
Trop Dis 8, e3255
7. Elso C, Kumar B, Smyth G, Foote S, Handman E (2004)
Dissociation of disease susceptibility, inflammation and cytokine
profile in lmr1/2 congenic mice infected with Leishmania major.
Genes Immun 5:188–196
8. Elso CM, Roberts LJ, Smyth GK, Thomson RJ, Baldwin TM et al
(2004) Leishmaniasis host response loci (lmr1-3) modify disease
severity through a Th1/Th2-independent pathway. Genes Immun
5:93–100
9. Gutierrez Y, Salinas GH, Palma G, Valderrama LB, Santrich CV
et al (1991) Correlation between histopathology, immune re-
sponse, clinical presentation, and evolution in Leishmania
braziliensis infection. Am J Trop Med Hyg 45:281–289
10. Souza-Lemos C, de-Campos SN, Teva A, Corte-Real S, Fonseca
EC et al (2008) Dynamics of immune granuloma formation in a
Leishmania braziliensis-induced self-limiting cutaneous infection
in the primate Macaca mulatta. J Pathol 216:375–386
11. Souza-Lemos C, de-Campos SN, Teva A, Porrozzi R, Grimaldi G
Jr (2011) In situ characterization of the granulomatous immune
response with time in nonhealing lesional skin of Leishmania
braziliensis-infected rhesus macaques (Macaca mulatta). Vet
Immunol Immunopathol 142:147–155
12. Kaye PM, Svensson M, Ato M, Maroof A, Polley R et al (2004)
The immunopathology of experimental visceral leishmaniasis.
Immunol Rev 201:239–253
13. Moreno A, Marazuela M, Yebra M, Hernandez MJ, Hellin T et al
(1988) Hepatic fibrin-ring granulomas in visceral leishmaniasis.
Gastroenterology 95:1123–1126
14. Geramizadeh B, Jahangiri R, Moradi E (2011) Causes of hepatic
granuloma: a 12-year single center experience from southern Iran.
Arch Iran Med 14:288–289
15. Zijlstra EE, el-Hassan AM (2001) Leishmaniasis in Sudan.
Visceral leishmaniasis. Trans R Soc Trop Med Hyg 95(Suppl 1):
S27–S58
16. Chandra H, Chandra S, Kaushik RM (2013) Visceral leishmania-
sis with associated common, uncommon, and atypical morpholog-
ical features on bone marrow aspirate cytology in nonendemic
region. J Trop Med 2013:861032
17. Dhingra KK, Gupta P, Saroha V, Setia N, Khurana N et al (2010)
Morphological findings in bone marrow biopsy and aspirate
smears of visceral Kala Azar: a review. Indian J Pathol
Microbiol 53:96–100
18. Pampiglione S, Manson-Bahr PE, Giungi F, Giunti G, Parenti A
et al (1974) Studies on Mediterranean leishmaniasis 2.
Asymptomatic cases of visceral leishmaniasis. Trans R Soc Trop
Med Hyg 68:447–453
19. dos-Santos WL, David J, Badaro R, de-Freitas LA (2004)
Association between skin parasitism and a granulomatous inflam-
matory pattern in canine visceral leishmaniosis. Parasitol Res 92:
89–94
20. Sanchez MA, Diaz NL, Zerpa O, Negron E, Convit J et al (2004)
Organ-specific immunity in canine visceral leishmaniasis:
analysis of symptomatic and asymptomatic dogs naturally
infected with Leishmania chagasi. Am J Trop Med Hyg 70:
618–624
21. Laurenti MD, Sotto MN, Corbett CE, da Matta VL, Duarte MI
(1990) Experimental visceral leishmaniasis: sequential events of
granuloma formation at subcutaneous inoculation site. Int J Exp
Pathol 71:791–797
22. Wilson ME, Innes DJ, Sousa AD, Pearson RD (1987) Early his-
topathology of experimental infection with Leishmania donovani
in hamsters. J Parasitol 73:55–63
23. Murray HW (2001) Tissue granuloma structure-function in exper-
imental visceral leishmaniasis. Int J Exp Pathol 82:249–267
24. Engwerda CR, Kaye PM (2000) Organ-specific immune re-
sponses associated with infectious disease. Immunol Today 21:
73–78
25. Ghosh MK, Nandy A, Addy M, Maitra TK, Ghose AC (1995)
Subpopulations of T lymphocytes in the peripheral blood, dermal
lesions and lymph nodes of post kala-azar dermal leishmaniasis
patients. Scand J Immunol 41:11–17
26. Khalil EA, Khidir SA, Musa AM, Musa BY, Elfaki ME et al
(2013) Post-kala-azar dermal leishmaniasis: a paradigm of para-
doxical immune reconstitution syndrome in non-HIV/AIDS pa-
tients. J Trop Med 2013:275253
27. Desjeux P, Ghosh RS, Dhalaria P, Strub-Wourgaft N, Zijlstra EE
(2013) Report of the post kala-azar dermal leishmaniasis (PKDL)
consortium meeting, New Delhi, India, 27–29 June 2012. Parasit
Vectors 6:196
Semin Immunopathol (2016) 38:249–260 257
28. Mukhopadhyay D, Dalton JE, Kaye PM, Chatterjee M (2014)
Post kala-azar dermal leishmaniasis: an unresolved mystery.
Trends Parasitol 30:65–74
29. Zijlstra EE, el-Hassan AM (2001) Leishmaniasis in Sudan. Post
kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg
95(Suppl 1):S59–S76
30. Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM
(2003) Post-kala-azar dermal leishmaniasis. Lancet Infect
Dis 3:87–98
31. Mukherjee S, Mukhopadhyay D, Braun C, Barbhuiya JN, Das NK
et al (2015) Decreased presence of Langerhans cells is a critical
determinant for Indian post kala-azar dermal leishmaniasis. Exp
Dermatol 24:232–234
32. Menard R, Tavares J, Cockburn I,MarkusM, Zavala F et al (2013)
Looking under the skin: the first steps in malarial infection and
immunity. Nat Rev Microbiol 11:701–712
33. McElrath MJ, Murray HW, Cohn ZA (1988) The dynamics of
granuloma formation in experimental visceral leishmaniasis. J
Exp Med 167:1927–1937
34. Gomez Perdiguero E, Geissmann F (2013) Myb-independent
macrophages: a family of cells that develops with their tissue of
residence and is involved in its homeostasis. Cold Spring Harb
Symp Quant Biol 78:91–100
35. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H,
Cagnard N et al (2012) A lineage of myeloid cells independent
of Myb and hematopoietic stem cells. Science 336:86–90
36. Beattie L, d’El-Rei Hermida M, Moore JW, Maroof A, Brown N
et al (2013) A transcriptomic network identified in uninfected
macrophages responding to inflammation controls intracellular
pathogen survival. Cell Host Microbe 14:357–368
37. Beattie L, Peltan A, Maroof A, Kirby A, Brown N et al (2010)
Dynamic imaging of experimental Leishmania donovani-induced
hepatic granulomas detects Kupffer cell-restricted antigen presen-
tation to antigen-specific CD8 T cells. PLoS Pathog 6, e1000805
38. Ueno N, Wilson ME (2012) Receptor-mediated phagocytosis of
Leishmania: implications for intracellular survival. Trends
Parasitol 28:335–344
39. Hsiao CH, Ueno N, Shao JQ, Schroeder KR, Moore KC et al
(2011) The effects of macrophage source on the mechanism of
phagocytosis and intracellular survival of Leishmania. Microbes
Infect 13:1033–1044
40. Lefevre L, Lugo-Villarino G, Meunier E, Valentin A, Olagnier D
et al (2013) The C-type lectin receptors dectin-1, MR, and
SIGNR3 contribute both positively and negatively to the macro-
phage response to Leishmania infantum. Immunity 38:1038–1049
41. Wenzel UA, Bank E, Florian C, Forster S, Zimara N et al (2012)
Leishmania major parasite stage-dependent host cell invasion and
immune evasion. FASEB J 26:29–39
42. Egen JG, Rothfuchs AG, Feng CG, Winter N, Sher A et al (2008)
Macrophage and T cell dynamics during the development
and disintegration of mycobacterial granulomas. Immunity
28:271–284
43. Davis JM, Ramakrishnan L (2009) The role of the granuloma in
expansion and dissemination of early tuberculous infection. Cell
136:37–49
44. Cotterell SE, Engwerda CR, Kaye PM (1999) Leishmania
donovani infection initiates T cell-independent chemokine re-
sponses, which are subsequently amplified in a T cell-dependent
manner. Eur J Immunol 29:203–214
45. Gupta G, Bhattacharjee S, Bhattacharyya S, Bhattacharya P,
Adhikari A et al (2009) CXC chemokine-mediated protection
against visceral leishmaniasis: involvement of the proinflammato-
ry response. J Infect Dis 200:1300–1310
46. Gupta G, Majumdar S, Adhikari A, Bhattacharya P, Mukherjee
AK et al (2011) Treatment with IP-10 induces host-protective
immune response by regulating the T regulatory cell functioning
in Leishmania donovani-infected mice. Med Microbiol Immunol
200:241–253
47. Majumder S, Bhattacharjee S, Paul Chowdhury B, Majumdar S
(2012) CXCL10 is critical for the generation of protective CD8 T
cell response induced by antigen pulsed CpG-ODN activated den-
dritic cells. PLoS One 7, e48727
48. Svensson M, Zubairi S, Maroof A, Kazi F, Taniguchi M et al
(2005) Invariant NKT cells are essential for the regulation of he-
patic CXCL10 gene expression during Leishmania donovani in-
fection. Infect Immun 73:7541–7547
49. Sato N, Kuziel WA, Melby PC, Reddick RL, Kostecki V et al
(1999) Defects in the generation of IFN-gamma are overcome to
control infection with Leishmania donovani in CC chemokine
receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-,
or CCR2-deficient mice. J Immunol 163:5519–5525
50. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr et al
(1997) Impaired monocyte migration and reduced type 1 (Th1)
cytokine responses in C-C chemokine receptor 2 knockout mice. J
Clin Invest 100:2552–2561
51. Gao JL, Wynn TA, Chang Y, Lee EJ, Broxmeyer HE et al (1997)
Impaired host defense, hematopoiesis, granulomatous inflamma-
tion and type 1-type 2 cytokine balance in mice lacking CC che-
mokine receptor 1. J Exp Med 185:1959–1968
52. Rostan O, Gangneux JP, Piquet-Pellorce C, Manuel C, McKenzie
AN et al (2013) The IL-33/ST2 axis is associated with human
visceral leishmaniasis and suppresses Th1 responses in the livers
of BALB/c mice infected with Leishmania donovani. MBio 4:
e00383–00313
53. Barbi J, Oghumu S, Rosas LE, Carlson T, Lu B et al (2007) Lack
of CXCR3 delays the development of hepatic inflammation but
does not impair resistance to Leishmania donovani. J Infect Dis
195:1713–1717
54. Seiler P, Aichele P, Bandermann S, Hauser AE, Lu B et al (2003)
Early granuloma formation after aerosol Mycobacterium tubercu-
losis infection is regulated by neutrophils via CXCR3-signaling
chemokines. Eur J Immunol 33:2676–2686
55. Robert-Gangneux F, Drogoul AS, Rostan O, Piquet-Pellorce C,
Cayon J et al (2012) Invariant NKT cells drive hepatic cytokinic
microenvironment favoring efficient granuloma formation and
early control of Leishmania donovani infection. PLoS One
7, e33413
56. Guerra CS, Silva RM, Carvalho LO, Calabrese KS, Bozza PTet al
(2010) Histopathological analysis of initial cellular response in
TLR-2 deficient mice experimentally infected by Leishmania
(L.) amazonensis. Int J Exp Pathol 91:451–459
57. Murray HW, Zhang Y, Zhang Y, Raman VS, Reed SG et al (2013)
Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in
Leishmania donovani infection in the liver. Infect Immun 81:
2318–2326
58. Schleicher U, Liese J, Knippertz I, Kurzmann C, Hesse A et al
(2007) NK cell activation in visceral leishmaniasis requires TLR9,
myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
J Exp Med 204:893–906
59. Tuon FF, Fernandes ER, Pagliari C, Duarte MI, Amato VS (2010)
The expression of TLR9 in human cutaneous leishmaniasis is
associated with granuloma. Parasite Immunol 32:769–772
60. Paun A, Bankoti R, Joshi T, Pitha PM, Stager S (2011) Critical
role of IRF-5 in the development of T helper 1 responses to
Leishmania donovani infection. PLoS Pathog 7, e1001246
61. Beattie L, Phillips R, BrownN, Owens BM, ChauhanN et al (2011)
Interferon regulatory factor 7 contributes to the control of
Leishmania donovani in the mouse liver. Infect Immun 79:
1057–1066
62. Rosas LE, Snider HM, Barbi J, Satoskar AA, Lugo-Villarino G
et al (2006) Cutting edge: STAT1 and T-bet play distinct roles in
258 Semin Immunopathol (2016) 38:249–260
determining outcome of visceral leishmaniasis caused by
Leishmania donovani. J Immunol 177:22–25
63. McFarlane E, Perez C, Charmoy M, Allenbach C, Carter KC et al
(2008) Neutrophils contribute to development of a protective im-
mune response during onset of infection with Leishmania
donovani. Infect Immun 76:532–541
64. Smelt SC, Cotterell SE, Engwerda CR, Kaye PM (2000) B cell-
deficient mice are highly resistant to Leishmania donovani infec-
tion, but develop neutrophil-mediated tissue pathology. J Immunol
164:3681–3688
65. Murray HW (1982) Cell-mediated immune response in experi-
mental visceral leishmaniasis. II. Oxygen-dependent killing of in-
tracellular Leishmania donovani amastigotes. J Immunol 129:
351–357
66. Engwerda CR, Ato M, Kaye PM (2004) Macrophages, pathology
and parasite persistence in experimental visceral leishmaniasis.
Trends Parasitol 20:524–530
67. Faleiro RJ, Kumar R, Hafner LM, Engwerda CR (2014) Immune
regulation during chronic visceral leishmaniasis. PLoS Negl Trop
Dis 8, e2914
68. McFarlane E, Carter KC, McKenzie AN, Kaye PM, Brombacher
F et al (2011) Endogenous IL-13 plays a crucial role in liver
granuloma maturation during Leishmania donovani infection, in-
dependent of IL-4R alpha-responsive macrophages and neutro-
phils. J Infect Dis 204:36–43
69. Stager S, Alexander J, Carter KC, Brombacher F, Kaye PM (2003)
Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling con-
tribute to the development of hepatic granulomas with optimal
antileishmanial activity. Infect Immun 71:4804–4807
70. Chen RY, Dodd LE, Lee M, Paripati P, Hammoud DA et al (2014)
PET/CT imaging correlates with treatment outcome in patients
with multidrug-resistant tuberculosis. Sci Transl Med 6:265ra166
71. Coleman MT, Chen RY, Lee M, Lin PL, Dodd LE et al (2014)
PET/CT imaging reveals a therapeutic response to oxazolidinones
in macaques and humans with tuberculosis. Sci Transl Med 6:
265ra167
72. Gideon HP, Phuah J, Myers AJ, Bryson BD, Rodgers MA et al
(2015) Variability in tuberculosis granuloma T cell responses ex-
ists, but a balance of pro- and anti-inflammatory cytokines is as-
sociated with sterilization. PLoS Pathog 11, e1004603
73. Tiwananthagorn S, Iwabuchi K, Ato M, Sakurai T, Kato H et al
(2012) Involvement of CD4(+) Foxp3(+) regulatory T cells in
persistence of Leishmania donovani in the liver of alymphoplastic
aly/aly mice. PLoS Negl Trop Dis 6, e1798
74. Bunn PT, Stanley AC, de Labastida RF,Mulherin A, Sheel M et al
(2014) Tissue requirements for establishing long-term CD4+ T
cell-mediated immunity following Leishmania donovani infec-
tion. J Immunol 192:3709–3718
75. Kong L, Tang J, Little JP, Yu Y, Lammermann T et al (2015)
Continuous volumetric imaging via an optical phase-locked ultra-
sound lens. Nat Methods 12:759–762
76. Egen JG, Rothfuchs AG, Feng CG, Horwitz MA, Sher A et al
(2011) Intravital imaging reveals limited antigen presentation and
T cell effector function in mycobacterial granulomas. Immunity
34:807–819
77. Torabi-Parizi P, Vrisekoop N, Kastenmuller W, Gerner MY, Egen
JG et al (2014) Pathogen-related differences in the abundance of
presented antigen are reflected in CD4+ T cell dynamic behavior
and effector function in the lung. J Immunol 192:1651–1660
78. Beattie L, Kaye PM (2011) Leishmania-host interactions: what
has imaging taught us? Cell Microbiol 13:1659–1667
79. Kaye PM, Rogers NJ, Curry AJ, Scott JC (1994) Deficient expres-
sion of co-stimulatory molecules on Leishmania-infected macro-
phages. Eur J Immunol 24:2850–2854
80. Cilfone NA, Perry CR, Kirschner DE, Linderman JJ (2013)Multi-
scale modeling predicts a balance of tumor necrosis factor-alpha
and interleukin-10 controls the granuloma environment during
Mycobacterium tuberculosis infection. PLoS One 8, e68680
81. Day J, Friedman A, Schlesinger LS (2009) Modeling the immune
rheostat of macrophages in the lung in response to infection. Proc
Natl Acad Sci U S A 106:11246–11251
82. Marino S, Cilfone NA, Mattila JT, Linderman JJ, Flynn JL et al
(2015) Macrophage polarization drives granuloma outcome
during Mycobacterium tuberculosis infection. Infect Immun
83:324–338
83. Moore JW,MoyoD, Beattie L, Andrews PS, Timmis J et al (2013)
Functional complexity of the Leishmania granuloma and the po-
tential of in silico modeling. Front Immunol 4:35
84. Albergante L, Timmis J, Beattie L, Kaye PM (2013) A Petri net
model of granulomatous inflammation: implications for IL-10me-
diated control of Leishmania donovani infection. PLoS Comput
Biol 9, e1003334
85. Carragher DM, Rangel-Moreno J, Randall TD (2008) Ectopic
lymphoid tissues and local immunity. Semin Immunol 20:26–42
86. Kahnert A, Hopken UE, Stein M, Bandermann S, Lipp M et al
(2007) Mycobacterium tuberculosis triggers formation of lym-
phoid structure in murine lungs. J Infect Dis 195:46–54
87. Maglione PJ, Xu J, Chan J (2007) B cells moderate inflammatory
progression and enhance bacterial containment upon pulmonary
challenge with Mycobacterium tuberculosis. J Immunol 178:
7222–7234
88. Ulrichs T, Kosmiadi GA, Trusov V, Jorg S, Pradl L et al (2004)
Human tuberculous granulomas induce peripheral lymphoid
follicle-like structures to orchestrate local host defence in the lung.
J Pathol 204:217–228
89. Buckley CD, Barone F, Nayar S, Benezech C, Caamano J (2015)
Stromal cells in chronic inflammation and tertiary lymphoid organ
formation. Annu Rev Immunol 33:715–745
90. Moore JW, Beattie L, Dalton JE, Owens BM, Maroof A et al
(2012) B cell: T cell interactions occur within hepatic granulomas
during experimental visceral leishmaniasis. PLoS One 7, e34143
91. Scandella E, Bolinger B, Lattmann E, Miller S, Favre S et al
(2008) Restoration of lymphoid organ integrity through the inter-
action of lymphoid tissue-inducer cells with stroma of the T cell
zone. Nat Immunol 9:667–675
92. Dalton JE, Maroof A, Owens BM, Narang P, Johnson K et al
(2010) Inhibition of receptor tyrosine kinases restores immuno-
competence and improves immune-dependent chemotherapy
against experimental leishmaniasis in mice. J Clin Invest 120:
1204–1216
93. Sharma P, Allison JP (2015) The future of immune checkpoint
therapy. Science 348:56–61
94. Topalian SL, Drake CG, Pardoll DM (2015) Immune checkpoint
blockade: a common denominator approach to cancer therapy.
Cancer Cell 27:450–461
95. Saha B, Das G, Vohra H, Ganguly NK, Mishra GC (1995)
Macrophage-T cell interaction in experimental visceral leishman-
iasis: failure to express costimulatory molecules on Leishmania-
infected macrophages and its implication in the suppression of
cell-mediated immunity. Eur J Immunol 25:2492–2498
96. Murphy ML, Engwerda CR, Gorak PM, Kaye PM (1997) B7-2
blockade enhances T cell responses to Leishmania donovani. J
Immunol 159:4460–4466
97. Murphy ML, Cotterell SE, Gorak PM, Engwerda CR, Kaye PM
(1998) Blockade of CTLA-4 enhances host resistance to the intra-
cellular pathogen, Leishmania donovani. J Immunol 161:
4153–4160
98. Zubairi S, Sanos SL, Hill S, Kaye PM (2004) Immunotherapy
with OX40L-Fc or anti-CTLA-4 enhances local tissue re-
sponses and killing of Leishmania donovani. Eur J Immunol 34:
1433–1440
Semin Immunopathol (2016) 38:249–260 259
99. Murray HW, Lu CM, Brooks EB, Fichtl RE, DeVecchio JL et al
(2003) Modulation of T-cell costimulation as immunotherapy or
immunochemotherapy in experimental visceral leishmaniasis.
Infect Immun 71:6453–6462
100. Joshi T, Rodriguez S, Perovic V, Cockburn IA, Stager S (2009)
B7-H1 blockade increases survival of dysfunctional CD8(+) T
cells and confers protection against Leishmania donovani infec-
tions. PLoS Pathog 5, e1000431
101. Gautam S, Kumar R, Singh N, Singh AK, Rai M et al (2014) CD8
T cell exhaustion in human visceral leishmaniasis. J Infect Dis
209:290–299
102. Esch KJ, Juelsgaard R, Martinez PA, Jones DE, Petersen CA
(2013) Programmed death 1-mediated T cell exhaustion during
visceral leishmaniasis impairs phagocyte function. J Immunol
191:5542–5550
103. Kirman J, McCoy K, Hook S, Prout M, Delahunt B et al (1999)
CTLA-4 blockade enhances the immune response induced by my-
cobacterial infection but does not lead to increased protection.
Infect Immun 67:3786–3792
104. Barber DL, Mayer-Barber KD, Feng CG, Sharpe AH, Sher A
(2011) CD4 T cells promote rather than control tuberculosis in
the absence of PD-1-mediated inhibition. J Immunol 186:
1598–1607
260 Semin Immunopathol (2016) 38:249–260
